Isophane Insulin Suspension
» Isophane Insulin Suspension is a sterile suspension of zinc-insulin crystals and Protamine Sulfate in buffered Water for Injection, combined in a manner such that the solid phase of the suspension consists of crystals composed of insulin, protamine, and zinc. The Protamine Sulfate is prepared from the sperm or from the mature testes of fish belonging to the genus Oncorhynchus Suckley, or Salmo Linné (Fam. Salmonidae). Its potency, based on the sum of its insulin and desamido insulin components, is not less than 95.0 percent and not more than 105.0 percent of the potency stated on the label, expressed in USP Insulin Units per mL.
Packaging and storage—
Preserve in the unopened multiple-dose container provided by the manufacturer. Do not repackage. Store in a refrigerator, protect from sunlight, and avoid freezing.
Labeling—
Label it to indicate the one or more animal species to which it is related, as porcine, as bovine, or as a mixture of porcine and bovine. Where it is purified, label it as such. The Suspension container label states that the Suspension is to be shaken carefully before use. The label states the potency in USP Insulin Units per mL. Label it to state that it is to be stored in a refrigerator and that freezing is to be avoided.
Bacterial endotoxins 
85
—
It contains not more than 80 USP Endotoxin Units per 100 USP Insulin Units.
85—
It contains not more than 80 USP Endotoxin Units per 100 USP Insulin Units.
Sterility 71—
It meets the requirements when tested as directed for Membrane Filtration under Test for Sterility of the Product to be Examined, the Suspension being filtered immediately after it has been reduced to a clear solution by the addition of a freshly prepared 1 in 100 solution of ascorbic acid in Fluid A.
71—
It meets the requirements when tested as directed for Membrane Filtration under Test for Sterility of the Product to be Examined, the Suspension being filtered immediately after it has been reduced to a clear solution by the addition of a freshly prepared 1 in 100 solution of ascorbic acid in Fluid A.
pH 791:
between 7.0 and 7.8, determined potentiometrically.
791:
between 7.0 and 7.8, determined potentiometrically.
Zinc content 591:
between 10 and 40 µg for each 100 USP Insulin Units.
591:
between 10 and 40 µg for each 100 USP Insulin Units.
Insulin in the supernatant—
Test solution—
Centrifuge 10 mL of the Suspension at 1500 × g for 10 minutes. Use the supernatant.
Procedure—
Determine the insulin content of the Test solution by a suitable method: the insulin concentration is not more than 1.0 USP Insulin Unit per mL.
Limit of high molecular weight proteins—
Proceed as directed in the test for Limit of high molecular weight proteins under Insulin Injection: not more than 3.0% is found.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
| Topic/Question | Contact | Expert Committee |
| Monograph | Larry N. Callahan, Ph.D.
Senior Scientist 1-301-816-8385 |
(BBPP05) Biologics and Biotechnology - Proteins and Polysaccharides |
| Reference Standards | Lili Wang, Technical Services Scientist 1-301-816-8129 RSTech@usp.org |
|
| 85 |
Radhakrishna S Tirumalai, Ph.D.
Senior Scientist 1-301-816-8339 |
(MSA05) Microbiology and Sterility Assurance |
| 71 |
Radhakrishna S Tirumalai, Ph.D.
Senior Scientist 1-301-816-8339 |
(MSA05) Microbiology and Sterility Assurance |
USP32–NF27 Page 2646
Pharmacopeial Forum: Volume No. 27(2) Page 2169